
Opinion|Videos|November 20, 2025
Using TDMs to Improve Care and Communication
Author(s)Jonathan M. Meyer, MD, DLFAPA
Reviewing TDM’s evidence-based rationale, its clinical utility, and connection to outcomes.
Advertisement
This video covers the following questions:
- Can you walk us through the typical therapeutic range—and what factors can influence individual variability?
- How can TDM help clinicians differentiate between treatment resistance due to pharmacokinetic factors (like metabolism) versus true nonresponse? and What role does TDM play in preventing toxicity, including dose-related adverse effects such as seizures or sedation?
- How might TDM support patient adherence and shared decision-making in clinical practice?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
2
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
3
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
4
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
5










